Bicara Therapeutics Inc. Common Stock (BCAX) — Strategic Asset Allocation Index
Bicara Therapeutics Inc. Common Stock (BCAX) has a Strategic Asset Allocation Index of 29.2% as of September 2025. Strategic assets (PP&E of $- plus long-term investments of $117.42 Million) total $117.42 Million, measured against net assets of $402.78 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See BCAX net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Annual Strategic Asset Allocation Index for Bicara Therapeutics Inc. Common Stock (None–None)
The table below presents the year-by-year Strategic Asset Allocation Index for Bicara Therapeutics Inc. Common Stock from None to None, covering 0 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See shareholders equity of Bicara Therapeutics Inc. Common Stock for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|